Laddar...
Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
INTRODUCTION: Glioblastoma (GBM) is the most lethal primary malignant brain tumor in adults with poor survival due to acquired therapeutic resistance and rapid recurrence. Currently, the standard clinical strategy for glioma includes maximum surgical resection, radiotherapy, and temozolomide (TMZ) c...
Sparad:
| I publikationen: | CNS Neurosci Ther |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053231/ https://ncbi.nlm.nih.gov/pubmed/31318172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13197 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|